Bakker Juliet Tammenoms - Net Worth and Insider Trading
Bakker Juliet Tammenoms Net Worth
The estimated net worth of Bakker Juliet Tammenoms is at least $414 Million dollars as of 2024-11-05. Bakker Juliet Tammenoms is the 10% Owner of Aimmune Therapeutics Inc and owns about 6,029,785 shares of Aimmune Therapeutics Inc (AIMT) stock worth over $208 Million. Bakker Juliet Tammenoms is the Director of Axonics Inc and owns about 1,959,859 shares of Axonics Inc (AXNX) stock worth over $138 Million. Bakker Juliet Tammenoms is also the Director of CeriBell Inc and owns about 2,481,728 shares of CeriBell Inc (CBLL) stock worth over $66 Million. Besides these, Bakker Juliet Tammenoms also holds RxSight Inc (RXST) , Eargo Inc (EAR) . Details can be seen in Bakker Juliet Tammenoms's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Bakker Juliet Tammenoms has not made any transactions after 2024-10-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Bakker Juliet Tammenoms
Bakker Juliet Tammenoms Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Bakker Juliet Tammenoms owns 20 companies in total, including Eargo Inc (EAR) , Axonics Inc (AXNX) , and Molecular Templates Inc (MTEM) among others .
Click here to see the complete history of Bakker Juliet Tammenoms’s form 4 insider trades.
Insider Ownership Summary of Bakker Juliet Tammenoms
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
EAR | Eargo Inc | 2020-10-20 | director & 10 percent owner |
AXNX | Axonics Inc | 2020-09-18 | director & 10 percent owner |
MTEM | Molecular Templates Inc | 2019-11-25 | 10 percent owner |
2020-07-23 | 10 percent owner | ||
2019-11-08 | 10 percent owner | ||
2020-06-11 | 10 percent owner | ||
2019-11-07 | director | ||
2019-11-22 | 10 percent owner | ||
2018-06-27 | 10 percent owner | ||
2018-06-20 | 10 percent owner | ||
2018-02-22 | 10 percent owner | ||
2015-05-06 | 10 percent owner | ||
2017-07-19 | 10 percent owner | ||
2008-03-25 | director & 10 percent owner | ||
2014-10-07 | 10 percent owner | ||
2024-05-17 | director | ||
2021-07-19 | 10 percent owner | ||
2021-05-06 | 10 percent owner | ||
2022-02-10 | 10 percent owner | ||
2023-11-02 | 10 percent owner |
Bakker Juliet Tammenoms Latest Holdings Summary
Bakker Juliet Tammenoms currently owns a total of 5 stocks. Among these stocks, Bakker Juliet Tammenoms owns 6,029,785 shares of Aimmune Therapeutics Inc (AIMT) as of February 22, 2018, with a value of $208 Million and a weighting of 50.18%. Bakker Juliet Tammenoms owns 1,959,859 shares of Axonics Inc (AXNX) as of September 18, 2020, with a value of $138 Million and a weighting of 33.29%. Bakker Juliet Tammenoms also owns 2,481,728 shares of CeriBell Inc (CBLL) as of October 15, 2024, with a value of $66 Million and a weighting of 15.96%. The other 2 stocks RxSight Inc (RXST) , Eargo Inc (EAR) have a combined weighting of 0.57% among all his current holdings.
Latest Holdings of Bakker Juliet Tammenoms
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
AIMT | Aimmune Therapeutics Inc | 2018-02-22 | 6,029,785 | 34.49 | 207,967,285 |
AXNX | Axonics Inc | 2020-09-18 | 1,959,859 | 70.40 | 137,964,274 |
CBLL | CeriBell Inc | 2024-10-15 | 2,481,728 | 26.65 | 66,138,051 |
RXST | RxSight Inc | 2024-05-17 | 36,388 | 51.53 | 1,874,892 |
EAR | Eargo Inc | 2020-10-20 | 195,935 | 2.57 | 503,553 |
Holding Weightings of Bakker Juliet Tammenoms
Bakker Juliet Tammenoms Form 4 Trading Tracker
According to the SEC Form 4 filings, Bakker Juliet Tammenoms has made a total of 0 transactions in Aimmune Therapeutics Inc (AIMT) over the past 5 years. The most-recent trade in Aimmune Therapeutics Inc is the acquisition of 9,375 shares on February 22, 2018, which cost Bakker Juliet Tammenoms around $300,000.
According to the SEC Form 4 filings, Bakker Juliet Tammenoms has made a total of 2 transactions in Axonics Inc (AXNX) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Axonics Inc is the sale of 9,167 shares on September 18, 2020, which brought Bakker Juliet Tammenoms around $391,156.
According to the SEC Form 4 filings, Bakker Juliet Tammenoms has made a total of 1 transactions in CeriBell Inc (CBLL) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in CeriBell Inc is the acquisition of 237,234 shares on October 15, 2024, which cost Bakker Juliet Tammenoms around $4 Million.
More details on Bakker Juliet Tammenoms's insider transactions can be found in the Insider Trading History of Bakker Juliet Tammenoms table.Insider Trading History of Bakker Juliet Tammenoms
- 1
Bakker Juliet Tammenoms Trading Performance
GuruFocus tracks the stock performance after each of Bakker Juliet Tammenoms's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Bakker Juliet Tammenoms is 16.18%. GuruFocus also compares Bakker Juliet Tammenoms's trading performance to market benchmark return within the same time period. The performance of stocks bought by Bakker Juliet Tammenoms within 3 months outperforms 4 times out of 7 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Bakker Juliet Tammenoms's insider trading performs compared to the benchmark.
Performance of Bakker Juliet Tammenoms
Bakker Juliet Tammenoms Ownership Network
Ownership Network List of Bakker Juliet Tammenoms
Ownership Network Relation of Bakker Juliet Tammenoms
Bakker Juliet Tammenoms Owned Company Details
What does Eargo Inc do?
Who are the key executives at Eargo Inc?
Bakker Juliet Tammenoms is the director & 10 percent owner of Eargo Inc. Other key executives at Eargo Inc include Chief Accounting Officer Mark Thorpe , Chief Operating Officer William Brownie , and Chief Financial Officer Adam Laponis .
Eargo Inc (EAR) Insider Trades Summary
Over the past 18 months, Bakker Juliet Tammenoms made no insider transaction in Eargo Inc (EAR). Other recent insider transactions involving Eargo Inc (EAR) include a net sale of 1,528 shares made by William Brownie , a net sale of 38 shares made by Adam Laponis , and a net sale of 6 shares made by Mark Thorpe .
In summary, during the past 3 months, insiders sold 0 shares of Eargo Inc (EAR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,630 shares of Eargo Inc (EAR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,630 shares.
Eargo Inc (EAR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Eargo Inc Insider Transactions
Bakker Juliet Tammenoms Mailing Address
Above is the net worth, insider trading, and ownership report for Bakker Juliet Tammenoms. You might contact Bakker Juliet Tammenoms via mailing address: Longitude Capital Management Co., Llc, 800 El Camino Real, Suite 220, Menlo Park Ca 94025.